Executive Team
• MAPS trained psychedelic therapist.
• Over 10 years working in private practice in the Bay area and 4 years working as an adherence rater for MAPS’ MDMA-assisted psychotherapy research for treating PTSD.
• President and Founder of the tax-exempt non-profit, Delos Psyche Research Group (delospsyche.org).
• Over 10 years working in private practice in the Bay area and 4 years working as an adherence rater for MAPS’ MDMA-assisted psychotherapy research for treating PTSD.
• President and Founder of the tax-exempt non-profit, Delos Psyche Research Group (delospsyche.org).
• Biotech engineer and Pharmacology PhD, with 20+ years of experience
• Over 10 years of practice in psychoactive drug development (Neuroresonance, DemeRx, Eleusis, Eastra Health)
• Over 10 years of practice in psychoactive drug development (Neuroresonance, DemeRx, Eleusis, Eastra Health)
Team
Researcher, Trained Psychedelic Therapist, Clinic Owner
Researcher, Digital Archivist
Neuropharmacology Researcher
Business Development
Clinical Trials Manager
Scientific Advisors
Associate Professor, Touro UC College of Pharmacy
Associate Professor, Psychiatry UCSD
Adjunct Professor, Psychiatry UCSD
Microdosing Researcher, Professor at Macquarie University
5-MeO-DMT Researcher, currently retired
Schedule 1 Clinical Trials Researcher, Faculty UCSF
DELOS Therapeutics
Manifesting Health, Wellness, and Wonder
“It does not seem to be an exaggeration to say that psychedelics used responsibly and with proper caution, would be for psychiatry what the microscope is for biology and medicine or the telescope is for astronomy.”